₹853.8▲0.11%
based on 5 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 5 analysts offering long term price targets for Glenmark Life Sciences Ltd. An average target of ₹932.6
Source: S&P Global Market Intelligence
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 2.32 % |
3 Month Return | + 3.19 % |
1 Year Return | + 34.04 % |
Market Stats | |
Previous Close | ₹852.85 |
Open | ₹857.00 |
Volume | 1.65L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹10,449.73Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹10,449.73 Cr |
P/B Ratio | 2.24 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | BUY | ₹10,449.73 Cr | 2.79% | 0.50 | NA | NA |
![]() | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
![]() | NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
![]() | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
![]() | NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Organisation | Glenmark Life Sciences Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Glenmark Life Sciences Ltd
Glenmark Life Sciences Ltd witnessed a significant increase in trading volume, with 9.6 lakh shares traded on the NSE, a 5.59 times surge over two-week average daily volume of 1.72 lakh shares. The stock increased by 2.46% to Rs.862.90.
Glenmark Pharma to Sell Stake in Glenmark Life Sciences - 11 Jul, 2024
Glenmark Pharma and Glen Saldanha plan to sell up to 7.85% of their stake in Glenmark Life Sciences through an OFS at a minimum price of Rs 810 per share. Following this, Glenmark Life Sciences' shares slumped by almost 4%. The OFS floor price was fixed at Rs 810 per share.
Glenmark Pharma to Sell Stake in Glenmark Life Sciences - 10 Jul, 2024
Glenmark Pharmaceuticals' board has approved the sale of its remaining 7.84% stake in Glenmark Life Sciences through an offer for sale (OFS) valued at approximately Rs 778 crore. The OFS will take place on July 11 and 12, with a floor price set at Rs 810 apiece.
Glenmark Life Sciences Registers High Volume on NSE - 03 Jul, 2024
Glenmark Life Sciences Ltd saw a surge in trading volume with 5.18 lakh shares traded on the NSE, an 8.33 fold increase from the two-week average daily volume. The stock also rose by 4.62% to reach Rs.925.65.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 10.73% to 10.76% in Jun 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 0.93% to 1.01% in Jun 2024 quarter
Price Rise
In the last 7 days, GLS stock has moved up by 0.2%
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 53.1%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 82.85% of holdings in Jun 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 5.01% to 4.82% in Jun 2024 quarter
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹2,703.98Cr | ↑9.38% |
Total Liabilities | ₹565.77Cr | ↑35.43% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹313.40Cr | ↓47.56% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 82.85% | 0.00 | |
Foreign Institutions | 4.82% | ||
Mutual Funds | 1.01% | 9.09 | |
Retail Investors | 10.76% | 0.29 | |
Others | 0.56% | 17.29 |
Glenmark Life Sciences Ltd’s net profit fell -33.08% since last year same period to ₹97.94Cr in the Q4 2023-2024. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated -17.54% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2023, Glenmark Life Sciences Ltd has declared dividend of ₹22.50 - translating a dividend yield of 5.10%.
Read More about DividendsBearish
Neutral
Bullish
Glenmark Life Sciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Glenmark Life Sciences Ltd (GLS) share price today is ₹853.8
Glenmark Life Sciences Ltd is listed on NSE
Glenmark Life Sciences Ltd is listed on BSE
Today’s traded volume of Glenmark Life Sciences Ltd(GLS) is 1.65L.
Today’s market capitalisation of Glenmark Life Sciences Ltd(GLS) is ₹10449.73Cr.
Glenmark Life Sciences Ltd(GLS | Price |
---|---|
52 Week High | ₹972 |
52 Week Low | ₹596 |
Glenmark Life Sciences Ltd(GLS) share price is ₹853.8. It is down -12.16% from its 52 Week High price of ₹972
Glenmark Life Sciences Ltd(GLS) share price is ₹853.8. It is up 43.26% from its 52 Week Low price of ₹596
Glenmark Life Sciences Ltd(GLS | Returns |
---|---|
1 Day Returns | 0.95% |
1 Month Returns | 2.32% |
3 Month Returns | 3.19% |
1 Year Returns | 34.04% |